ESR1 and breast carcinoma: In pilot experiments, a significant and dose-dependent increase in BAF growth was detectable when cells were cultured in the presence of serum-free CM from ERα-negative MDA-MB231 breast cancer cells (more than 2-fold increase at 50% CM, Figure 1A).